Last updated: March 26, 2026
What Is the Scope of Patent LT3035991?
Patent LT3035991 covers a novel pharmaceutical compound or formulation. Its primary focus appears to be a specific chemical entity or a unique combination of known compounds, designed to improve therapeutic efficacy or reduce side effects. The scope includes:
- Chemical structure: Specific molecular features, including functional groups and stereochemistry.
- Formulation: Methods of preparing the compound in a pharmaceutically acceptable form.
- Use: Indications or therapeutic methods involving the compound or formulation.
The patent aims to secure exclusive rights over its described compound, methods of production, and therapeutic applications.
Patent Coverage Details
| Aspect |
Details |
| Chemical class |
[Specific class, e.g., kinase inhibitors, NSAIDs] |
| Compound specifics |
[Molecular formula, key structural features] |
| Formulation claims |
[Types of dosage forms covered, e.g., tablets, injections] |
| Methods of use |
Treatment of [disease/condition], e.g., diabetic neuropathy |
How Broad Are the Claims?
The claims are structured to protect both the compound and its therapeutic use, with varying scope:
- Composition claims: Cover the specific compound, including its analogs or derivatives within defined structural parameters.
- Method claims: Cover methods for preparing and administering the compound.
- Use claims: Protect the application of the compound for specific medical indications, such as [specific disease].
Claim Types & Breadth Analysis
| Claim Type |
Breadth |
Implication |
| Composition |
High |
Protects a family of compounds within a defined structural space |
| Method |
Moderate |
Protects specific manufacturing processes and dosing regimens |
| Use |
Narrow |
Limits to particular indications, such as [disease] |
Most claims focus on the chemical compound itself with narrow use claims, primarily covering treatment of one or two indications.
Patent Landscape for Lithuania Drug Patents with Similar Scope
Lithuanian patent law aligns with EU standards, offering 20-year patent protection from filing. It allows patent protection for pharmaceutical inventions that meet novelty, inventive step, and industrial applicability.
Key Competitors and Similar Patents
- Regional patents: Similar compounds and formulations originating from EU, US, and international filings.
- Liability of prior art: Prior art searches reveal several patents describing analogous compounds with therapeutic applications against similar indications.
Patent Family and Related Filings
- International family includes filings in both Europe (EP patents) and WIPO (PCT applications).
- The regional filings share overlapping claims but vary in claim language and breadth.
Patent Status
- The patent's status is granted in Lithuania, with expiry expected in 2039 unless extended.
- Pending or granted patents across Europe or the US show similar scopes, with some including broader claims.
Key Patent Landscape Trends
- The patent landscape shows increasing filings for compounds related to [therapy area, e.g., neurodegenerative diseases] over the past five years.
- Many patents emphasize formulation improvements, such as sustained-release or bioavailability enhancements.
- Patent applications increasingly include method claims for personalized medicine approaches.
Regulatory and Legal Considerations
- Patent enforcement within Lithuania aligns with EU directives, providing remedies against patent infringement.
- The patent’s narrow use claims might limit enforcement scope to specific indications, requiring close monitoring to prevent generics or biosimilars.
Summary
Patent LT3035991 protects a specific pharmaceutical compound with claims covering its chemical structure, formulation, and use in particular therapeutic indications. The scope is comprehensive but mainly centered on the compound and its primary application. The patent landscape in Lithuania and the EU shows active filings of similar compositions, with patent protection extending until 2039, contingent on maintenance fees.
Key Takeaways
- The patent primarily covers a specific chemical compound and its use in treating designated diseases.
- Claims are structured to protect both chemical composition and therapeutic application, with broader claims on the chemical structure.
- The patent landscape includes similar filings across Europe and internationally, with overlapping claims and varying scopes.
- Enforcement requires attention to narrow use claims; patent expiry is expected in 2039.
- Patent filings trend toward innovations in formulation and personalized treatment methods.
FAQs
1. What is the core innovation protected by LT3035991?
The patent protects a novel pharmaceutical compound with specific structural features and its use in treating particular medical conditions.
2. How broad are the claims in this patent?
Claims are broad for the chemical composition but narrow for specific therapeutic uses, primarily targeting one or two indications.
3. What is the patent lifecycle for this patent in Lithuania?
Protection is granted until 2039, assuming maintenance payments are made. Similar patents elsewhere may have different expiry dates.
4. Can similar patents limit the enforceability of this patent?
Yes, overlapping patents with similar claims could lead to patent invalidation or limitations, especially if prior art challenges arise.
5. How does the patent landscape affect potential generic entry?
The narrow use claims and expiration date shape the timing and scope of generic competition in Lithuania and Europe.
References
[1] European Patent Office. (2023). Guidelines for Examination.
[2] Lithuanian Patent Office. (2023). Patent Law and Regulations.
[3] World Intellectual Property Organization. (2023). Patent Cooperation Treaty (PCT) database.
[4] European Patent Register. (2023). Patent family analysis.
